Since SDHA mutations were initially associated with PCC/PGL the spectrum of associated tumors has expanded to also include HNPGL, GIST, renal tumors, and pituitary adenoma (PA) (Pantaleo et al. The gene discussed is SDHA; the disease is gastrointestinal stromal tumor.